Photobiomodulation for Dry Age Related Macula Degeneration
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorOslo University Hospital
About this trial
The study will investigate the effect of photobiomodulation treatment on the risk of developing late age related macula degeneration (AMD) in the study eye in patients with wet AMD in the fellow eye.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with dry AMD in the study eye and wet AMD in the control eye
Disqualifiers
Geographic atrophy of the central macular region at enrolment
Previous/ active wet AMD in the study eye
A history of epilepsy
Retinal diseases apart from AMD
Trial design
Design model
Parallel
Treatments tested in this trial
Valeda machine
DevicePhotobiomodulation treatment with Valeda machine will be applied every six months for 2 years in patients with dry age related macula degeneration.
Treatment groups
121 Participants
are divided into 2 treatment groupsGroup A: InterventionExperimental treatment 1 intervention
Group B: ControlSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Percentage of patients that develope late AMD in the study eye compared with control after 3 years of follow-up
Time frame
3 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: